Tremelimumab and CP-870,893 in Patients With Metastatic Melanoma
Clinical trial NCT01103635 · COMPLETED
Trial details
- NCT number
- NCT01103635
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2016-05-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.